These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8305289)

  • 1. Warfarin metabolites: stereochemical aspects of protein binding and displacement by phenylbutazone.
    Chan E; McLachlan AJ; Rowland M
    Chirality; 1993; 5(8):610-5. PubMed ID: 8305289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein-binding high-performance frontal analysis of (R)- and (S)-warfarin on HSA with and without phenylbutazone.
    He J; Shibukawa A; Tokunaga S; Nakagawa T
    J Pharm Sci; 1997 Jan; 86(1):120-5. PubMed ID: 9002471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone.
    Lewis RJ; Trager WF; Chan KK; Breckenridge A; Orme M; Roland M; Schary W
    J Clin Invest; 1974 Jun; 53(6):1607-17. PubMed ID: 4830225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site I on human albumin: differences in the binding of (R)- and (S)-warfarin.
    Bertucci C; Canepa A; Ascoli GA; Guimaraes LF; Felix G
    Chirality; 1999; 11(9):675-9. PubMed ID: 10506426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enantioselective gallopamil protein binding.
    Gross AS; Eser C; Mikus G; Eichelbaum M
    Chirality; 1993; 5(6):414-8. PubMed ID: 8398599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked enantioselective protein binding in humans of ketorolac in vitro: elucidation of enantiomer unbound fractions following facile synthesis and direct chiral HPLC resolution of tritium-labelled ketorolac.
    Hayball PJ; Holman JW; Nation RL; Massy-Westropp RA; Hamon DP
    Chirality; 1994; 6(8):642-8. PubMed ID: 7857775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ethanol on the binding of warfarin enantiomers to human serum albumin.
    Tatsumi A; Kadobayashi M; Iwakawa S
    Biol Pharm Bull; 2007 Apr; 30(4):826-9. PubMed ID: 17409531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of warfarin enantiomers and hydroxylated metabolites in human blood plasma by liquid chromatography with achiral and chiral separation.
    Locatelli I; Kmetec V; Mrhar A; Grabnar I
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Apr; 818(2):191-8. PubMed ID: 15734158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous determination of warfarin enantiomers and its metabolite in human plasma by column-switching high-performance liquid chromatography with chiral separation.
    Uno T; Niioka T; Hayakari M; Sugawara K; Tateishi T
    Ther Drug Monit; 2007 Jun; 29(3):333-9. PubMed ID: 17529891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Competition between serum albumin and soluble fraction of liver for binding of warfarin and other drugs.
    Wosilait WD; Ryan MP; Byington KH
    Res Commun Chem Pathol Pharmacol; 1981 Apr; 32(1):113-21. PubMed ID: 7291718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective protein binding of ketoprofen: effect of albumin concentration and of the biological system.
    Dubois N; Lapicque F; Abiteboul M; Netter P
    Chirality; 1993; 5(3):126-34. PubMed ID: 8338722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereoselective binding of etodolac to human serum albumin.
    Muller N; Lapicque F; Monot C; Payan E; Dropsy R; Netter P
    Chirality; 1992; 4(4):240-6. PubMed ID: 1389961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenylbutazone-warfarin interaction in man: further stereochemical and metabolic considerations.
    Banfield C; O'Reilly R; Chan E; Rowland M
    Br J Clin Pharmacol; 1983 Dec; 16(6):669-75. PubMed ID: 6661352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of interaction between drug enantiomers and serum albumin by capillary electrophoresis.
    Ding Y; Zhu X; Lin B
    Electrophoresis; 1999 Jul; 20(9):1890-4. PubMed ID: 10445331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical-grade albumin: impaired drug-binding capacity in vitro.
    Olsen H; Andersen A; Nordbø A; Kongsgaard UE; Børmer OP
    BMC Clin Pharmacol; 2004 Mar; 4():4. PubMed ID: 15046641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved chromatographic performance of a modified human albumin based stationary phase.
    Bertucci C; Wainer IW
    Chirality; 1997; 9(4):335-40. PubMed ID: 9275312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective inhibition of warfarin metabolism by diltiazem in humans.
    Abernethy DR; Kaminsky LS; Dickinson TH
    J Pharmacol Exp Ther; 1991 Apr; 257(1):411-5. PubMed ID: 2020000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoselective effect of warfarin and bilirubin on the binding of 5-(o-chlorophenyl)-1,3-dihydro-3-methyl-7-nitro-2H-1,4-benzodiazepin-2- one enantiomers to human serum albumin.
    Fitos I; Visy J; Magyar A; Kajtár J; Simonyi M
    Chirality; 1990; 2(3):161-6. PubMed ID: 1979230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of unbound warfarin enantiomers in human plasma and 7-hydroxywarfarin in human urine by chiral stationary-phase liquid chromatography with ultraviolet or fluorescence and on-line circular dichroism detection.
    Takahashi H; Kashima T; Kimura S; Muramoto N; Nakahata H; Kubo S; Shimoyama Y; Kajiwara M; Echizen H
    J Chromatogr B Biomed Sci Appl; 1997 Nov; 701(1):71-80. PubMed ID: 9389340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Warfarin: stereochemical aspects of its metabolism in vivo in the rat.
    Pohl LR; Bales R; Trager WF
    Res Commun Chem Pathol Pharmacol; 1976 Oct; 15(2):233-56. PubMed ID: 981784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.